The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab

Authors: Karl-Anton Kreuzer, Richard R. Furman, Stephan Stilgenbauer, Ronald L. Dubowy, Yeonhee Kim, Veerendra Munugalavadla, Esther Lilienweiss, Hans Christian Reinhardt, Paula Cramer, Barbara Eichhorst, Peter Hillmen, Susan M. O’Brien, Andrew R. Pettitt, Michael Hallek

Published: 2019-08-19

DOI: 10.1038/s41375-019-0533-6

Source: Full article

---

Abstract

No abstract found.